SuperworthAkebia Therapeutics market cap AKBA
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $157.1M
- Highest close in our data
- $1.7B
- Jul 2020
Akebia Therapeutics is worth $157.1M at the close on Oct 23, 2026, at $0.57 a share.
That is down 80% over the last year and down 69% over five years.
Its highest close in our data was $1.7B in Jul 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $157.1M | $157.1M | $411.3M | −64% |
| 2025 | $440.5M | $381.8M | $1B | +4% |
| 2024 | $425.5M | $190.7M | $454.3M | +82% |
| 2023 | $233.6M | $99.5M | $301.2M | +120% |
| 2022 | $106.1M | $47.1M | $473M | −73% |
| 2021 | $395.4M | $395.4M | $672.5M | −2% |
| 2020 | $404.7M | $318.2M | $1.7B | −48% |
| 2019 | $775.5M | $308.7M | $959.2M | +152% |
| 2018 | $307.5M | $307.5M | $741.2M | −56% |
| 2017 | $702.9M | $352.2M | $927.5M | +76% |
| 2016 | $399M | $224.5M | $406.2M | +1% |
| 2015 | $395.8M | $154M | $395.8M | +69% |
| 2014 | $233.7M | $212.6M | $591.1M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Akebia Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| AKBAAkebia Therapeutics | $157.1M |
| NATRNatures Sunshine Products | $213.8M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| ARVNArvinas | $477.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $523.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Akebia Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.